Telomir Pharmaceuticals, Inc. Common Stock Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/07/2025 | 1.10 M | $1.53 M | -1.47% | 3.67% |
| BLACKROCK, INC. | 11/12/2025 | 291.43 K | $405.09 K | -21.25% | 0.97% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 222.40 K | $309.14 K | -10.21% | 0.74% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 196.03 K | $272.63 K | -0.43% | 0.65% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 75.34 K | $104.72 K | 4,101.90% | 0.25% |
| UBS GROUP AG | 11/13/2025 | 63.54 K | $88.31 K | 30.38% | 0.21% |
| STATE STREET CORP | 11/14/2025 | 58.60 K | $81.45 K | -4.87% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 51.45 K | $71.52 K | 0.00% | 0.17% |
| SUNCOAST EQUITY MANAGEMENT | 10/21/2025 | 51.19 K | $71.16 K | 0.00% | 0.17% |
| NORTHERN TRUST CORP | 11/14/2025 | 41.84 K | $58.16 K | 0.00% | 0.14% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 24.51 K | $32.50 K | 16.94% | 0.08% |
| RESOURCES INVESTMENT ADVISORS, LLC. | 11/10/2025 | 23.00 K | $31.97 K | 64.29% | 0.08% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 22.64 K | $31.46 K | -85.90% | 0.08% |
| PRAETORIAN WEALTH MANAGEMENT, INC. | 10/15/2025 | 20.00 K | $27.80 K | 100.00% | 0.07% |
| MARINER, LLC | 11/14/2025 | 19.99 K | $27.79 K | 100.00% | 0.07% |
| JANE STREET GROUP, LLC | 11/14/2025 | 19.78 K | $27.49 K | -60.10% | 0.07% |
| CLEARSTEAD ADVISORS, LLC | 11/10/2025 | 12.53 K | $17.42 K | 100.00% | 0.04% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 11.02 K | $15.31 K | -58.45% | 0.04% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 11/17/2025 | 11.00 K | $15.29 K | 100.00% | 0.04% |
| REGIONS FINANCIAL CORP | 11/19/2025 | 10.64 K | $14.79 K | 100.00% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 1.25 K | $1.74 K | -85.53% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 11/04/2025 | 600 | $834 | 0.00% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2025 | 599 | $1.00 K | -36.55% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 11/10/2025 | 379 | $527 | 723.91% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 347 | $482 | -72.48% | 0.00% |
| MORGAN STANLEY | 11/14/2025 | 334 | $464 | -98.69% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 23 | $32 | -99.69% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 11/14/2025 | 9 | $12 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 4 | $6 | 0.00% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 2 | $3 | -99.93% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 1 | $1 | -99.95% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 10/23/2025 | 0 | $0 | -100.00% | 0.00% |
| MARSHALL WACE, LLP | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CWM, LLC | 10/15/2025 | 0 | $0 | -100.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 12/02/2025 | 0 | $0 | -100.00% | 0.00% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| Y-INTERCEPT (HONG KONG) LTD | 10/31/2025 | 0 | $0 | -100.00% | 0.00% |
| FORTITUDE FAMILY OFFICE, LLC | 10/17/2025 | 0 | $0 | -100.00% | 0.00% |
| TRUE WEALTH DESIGN, LLC | 10/21/2025 | 0 | $0 | -100.00% | 0.00% |
| TACTIVE ADVISORS, LLC | 10/14/2025 | 0 | $0 | -100.00% | 0.00% |
| JAIN GLOBAL LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Telomir Pharmaceuticals, Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 49 institutional investors and hedge funds held shares of Telomir Pharmaceuticals, Inc. Common Stock. The most heavily invested institutionals were:
VANGUARD GROUP INC: 1.1 M
BlackRock, Inc.: 291,433
MILLENNIUM MANAGEMENT LLC: 222,404
GEODE CAPITAL MANAGEMENT, LLC: 196,030
RAYMOND JAMES FINANCIAL INC: 75,340
UBS Group AG: 63,536
7.77% of Telomir Pharmaceuticals, Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 2.45 M shares in the last 24 months. This purchase volume represents approximately $3.42 M in transactions.